دورية أكاديمية
أعرض في EDS

Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

التفاصيل البيبلوغرافية
العنوان: Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.
المؤلفون: Edwards K; Medical Center North, Vanderbilt University School of Medicine, Nashville, TN, D7227, USA. Electronic address: Kathryn.edwards@vumc.org., Hanquet G; Brussels, and Antwerp University, Universiteitsplein 1, 2610, Antwerp, Belgium. Electronic address: ghanquet@skynet.be., Black S; Cincinnati Children's Hospital, Cincinnati, OH, USA., Mignot E; Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, USA., Jankosky C; Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Shimabukuro T; Immunization Safety Office, Centers for Disease Control and Prevention (CDC), 1600, Clifton Road, Atlanta, GA, USA. Electronic address: TShimabukuro@cdc.gov., Miller E; Public Health England, London, United Kingdom., Nohynek H; National Institute for Health and Welfare THL Department of Health Security, Infectious Disease Control and Vaccinations Unit Helsinki, Finland., Neels P; IABS, Rue de la Vallée 3, 1204, Genève, Switzerland. Electronic address: pieter.neels@vaccine-vaccine.be.
المصدر: Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2019 Jul; Vol. 60, pp. 1-7. Date of Electronic Publication: 2019 May 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Academic Press Country of Publication: England NLM ID: 9004494 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8320 (Electronic) Linking ISSN: 10451056 NLM ISO Abbreviation: Biologicals Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London ; San Diego : Academic Press, c1990-
مواضيع طبية MeSH: Influenza Vaccines*/administration & dosage , Influenza Vaccines*/adverse effects , Influenza, Human*/epidemiology , Influenza, Human*/immunology , Influenza, Human*/prevention & control , Narcolepsy*/chemically induced , Narcolepsy*/epidemiology , Narcolepsy*/immunology , Pandemics* , Vaccination*, Influenza A Virus, H1N1 Subtype/*immunology, Biological Science Disciplines ; Congresses as Topic ; Female ; Humans ; Male ; Societies, Scientific
مستخلص: A group of scientific and public health experts and key stakeholders convened to discuss the state of knowledge on the relationship between adjuvanted monovalent inactivated 2009 influenza A H1N1 vaccines used during the 2009 influenza pandemic and narcolepsy. There was consensus that an increased risk of narcolepsy was consistently observed after Pandemrix (AS03-adjuvanted) vaccine, but similar associations following Arepanrix (AS03-adjuvanted) or Focetria (MF59-adjuvanted) vaccines were not observed. Whether the differences are due to vaccine composition or other factors such as the timing of large-scale vaccination programs relative to H1N1pdm09 wild-type virus circulation in different geographic regions is not clear. The limitations of retrospective observational methodologies could also be contributing to some of the differences across studies. More basic and epidemiologic research is needed to further elucidate the association between adjuvanted influenza vaccine and narcolepsy and its mechanism and to inform planning and preparation for vaccination programs in advance of the next influenza pandemic.
(Copyright © 2019.)
References: J Infect Dis. 2002 Jan 1;185(1):114-7. (PMID: 11756990)
BioDrugs. 2008;22(5):279-92. (PMID: 18778110)
MMWR Morb Mortal Wkly Rep. 2009 May 8;58(17):453-8. (PMID: 19444146)
Euro Surveill. 2009 Oct 15;14(41):19361. (PMID: 19883538)
Vaccine. 2010 May 14;28(22):3758-66. (PMID: 20380902)
Pediatrics. 2011 May;127(5):e1161-8. (PMID: 21464195)
Scand J Infect Dis. 2011 Sep;43(9):702-6. (PMID: 21534891)
Ann Neurol. 2011 Sep;70(3):410-7. (PMID: 21866560)
BMJ. 2011 Oct 12;343:d5956. (PMID: 21994316)
Euro Surveill. 2012 Jan 26;17(4):null. (PMID: 22297139)
PLoS One. 2012;7(3):e33536. (PMID: 22470453)
PLoS One. 2012;7(3):e33723. (PMID: 22470463)
Vaccine. 2012 Dec 14;30(52):7439-42. (PMID: 23088885)
Vaccine. 2013 Feb 6;31(8):1246-54. (PMID: 23246544)
Influenza Other Respir Viruses. 2013 Sep;7(5):872-86. (PMID: 23331969)
BMJ. 2013 Feb 26;346:f794. (PMID: 23444425)
PLoS One. 2013 Aug 08;8(8):e68402. (PMID: 23950869)
BMC Infect Dis. 2013 Sep 16;13:435. (PMID: 24041010)
PLoS Genet. 2013 Oct;9(10):e1003880. (PMID: 24204295)
Hum Vaccin Immunother. 2014;10(3):572-6. (PMID: 24342916)
Sleep. 2014 Jan 01;37(1):19-25. (PMID: 24381371)
Sleep Med. 2014 Jun;15(6):607-13. (PMID: 24767723)
Euro Surveill. 2014 May 01;19(17):15-25. (PMID: 24821121)
Sleep. 2014 Oct 01;37(10):1601-8. (PMID: 25197808)
PLoS One. 2014 Sep 29;9(9):e108489. (PMID: 25264897)
Neurology. 2014 Nov 11;83(20):1823-30. (PMID: 25320099)
Brain Behav Immun. 2015 Jul;47:44-57. (PMID: 25452148)
Am J Hum Genet. 2015 Jan 8;96(1):136-46. (PMID: 25574827)
Vaccine. 2015 May 21;33(22):2558-61. (PMID: 25869891)
Vaccine. 2015 Jun 8;33 Suppl 2:B6-B13. (PMID: 26022571)
J Intern Med. 2015 Oct;278(4):335-53. (PMID: 26123389)
Sci Transl Med. 2015 Jul 1;7(294):294ra105. (PMID: 26136476)
JAMA. 2015 Jul 21;314(3):237-46. (PMID: 26197184)
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E368-77. (PMID: 26668381)
PLoS One. 2016 Mar 24;11(3):e0151575. (PMID: 27010830)
Biologicals. 2016 Jul;44(4):276-280. (PMID: 27329008)
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10956-61. (PMID: 27621438)
Vaccine. 2017 Apr 4;35(15):1879-1885. (PMID: 28302408)
Vaccine. 2017 Apr 11;35(16):1996-2006. (PMID: 28302409)
Sleep Med. 2017 Jun;34:71-83. (PMID: 28522102)
J Sleep Res. 2018 Apr;27(2):268-272. (PMID: 28568319)
Sleep Med Rev. 2018 Apr;38:177-186. (PMID: 28847694)
Vaccine. 2018 Oct 1;36(41):6202-6211. (PMID: 30122647)
Sleep Med. 2018 Nov 26;:null. (PMID: 30579702)
معلومات مُعتمدة: CC999999 United States Intramural CDC HHS
فهرسة مساهمة: Keywords: Adjuvants; Antigen system 03 (AS03); H1N1pdm09 influenza vaccines; Narcolepsy; Pandemic influenza; Pandemrix vaccine
المشرفين على المادة: 0 (Influenza Vaccines)
تواريخ الأحداث: Date Created: 20190528 Date Completed: 20191219 Latest Revision: 20200701
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6668612
DOI: 10.1016/j.biologicals.2019.05.005
PMID: 31130313
قاعدة البيانات: MEDLINE
الوصف
تدمد:1095-8320
DOI:10.1016/j.biologicals.2019.05.005